4.4001
-0.8799 (-16.66%)
-0.8799 (-16.66%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InflaRx NV | IFRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.8799 | -16.66% | 4.4001 | 11:44:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.10 | 4.373 | 5.10 | 5.28 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.40 | 4.41 | 0.01 | - | 2 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,682 | 1,456,065 | $ 4.61 | $ 6,707,543 | 366,944 | 2.52 - 9.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:44:55 | 3,000 | $ 4.4001 | USD |
InflaRx NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 124.21M | 28.23M | 23.88M | $ - | $ - | -2.36 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
InflaRx NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IFRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.30 | 6.38 | 4.373 | 5.59 | 264,736 | -1.90 | -30.16% |
| 1 Month | 5.58 | 6.38 | 4.373 | 5.73 | 320,421 | -1.18 | -21.15% |
| 3 Months | 3.91 | 6.88 | 3.91 | 5.52 | 338,529 | 0.4901 | 12.53% |
| 6 Months | 4.12 | 6.88 | 3.50 | 4.91 | 332,695 | 0.2801 | 6.8% |
| 1 Year | 4.30 | 9.70 | 2.52 | 5.51 | 717,047 | 0.1001 | 2.33% |
| 3 Years | 31.84 | 53.10 | 2.17 | 6.77 | 520,585 | -27.44 | -86.18% |
| 5 Years | 15.19 | 53.10 | 2.17 | 6.96 | 482,349 | -10.79 | -71.03% |
InflaRx NV Description
| InflaRx NV is a clinical-stage biopharmaceutical company is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction. |
